ACM
TLIS

ADAR1 Capital Management’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

ADAR1 Capital Management’s Portfolio TLIS Stock Details TLIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-300
Closed -$2.63K – 321
2024
Q1 		$2.63K Buy
+300
New +$2.47K ﹤0.01% 246

Other funds holding TLIS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

ADAR1 Capital Management's TLIS Position: Q2 2024 in Review

ADAR1 Capital Management sold out of Talis Biomedical Corporation Common Stock (TLIS) in Q2 2024, closing a stake of 300 shares — an estimated $2.63K sold.

ADAR1 Capital Management first reported a position in TLIS in Q1 2024 and held it in 1 quarter. The position peaked at $2.63K in Q1 2024. 18 funds tracked by Wall St. Rank hold TLIS as of Q2 2024.

  • ADAR1 Capital Management reported no remaining Talis Biomedical Corporation Common Stock position as of Q2 2024 after selling out during the quarter.
  • ADAR1 Capital Management sold 300 Talis Biomedical Corporation Common Stock shares in Q2 2024, an estimated $2.63K.
  • ADAR1 Capital Management first reported a position in Talis Biomedical Corporation Common Stock in Q1 2024 and held it in 1 quarter.
  • ADAR1 Capital Management's Talis Biomedical Corporation Common Stock position peaked at $2.63K in Q1 2024.
  • 18 funds tracked by Wall St. Rank held Talis Biomedical Corporation Common Stock as of Q2 2024.

Based on ADAR1 Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.